NEUROGENE INC (NGNE) Stock Balance Sheet
USA - NASDAQ:NGNE - US64135M1053 - Common Stock
29.26 USD
-1.82 (-5.86%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 136.59M | 148.21M | 37.89M | 142.47M | 192.56M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 175.82M | 48.95M | 58.50M | null | null | |||
| Receivables | 648.00K | null | null | null | 900.00K | |||
| Inventories | null | null | null | null | null | |||
| Other Current Assets | 2.87M | 3.19M | 2.75M | 1.52M | 1.07M | |||
| Total Current Assets | 315.92M | 200.35M | 99.13M | 143.99M | 194.52M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.49M | 20.95M | 15.88M | 17.22M | 13.72M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | null | null | 0 | 128.00K | 347.00K | |||
| Other Non-Current Assets | 1.31M | 1.27M | 936.00K | 1.93M | 1.93M | |||
| Total Non-Current Assets | 19.81M | 22.23M | 16.81M | 19.27M | 16.00M | |||
| TOTAL ASSETS | 335.73M | 222.57M | 115.95M | 163.26M | 210.52M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 54.00K | 42.00K | 140.00K | 55.00K | 49.00K | |||
| Accrued Expenses | 12.33M | 20.05M | 10.44M | 8.05M | 6.52M | |||
| Accounts Payable | 1.34M | 2.60M | 478.00K | 526.00K | 1.32M | |||
| Other Current Liabilities | 1.43M | 281.00K | null | null | null | |||
| Total Current Liabilities | 15.16M | 22.97M | 11.06M | 8.64M | 7.89M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 26.00K | 65.00K | 233.00K | 67.00K | 108.00K | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 10.17M | 13.51M | 10.32M | 11.70M | 11.31M | |||
| Total Non-Current Liabilities | 10.20M | 13.58M | 10.55M | 11.76M | 11.41M | |||
| TOTAL LIABILITIES | 25.36M | 36.55M | 21.62M | 20.40M | 19.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -262.30M | -187.15M | -451.06M | -393.50M | -332.81M | |||
| Additional Paid In Capital | 572.67M | 373.18M | 545.41M | 536.36M | 524.02M | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 0 | 0 | 0 | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 0 | 0 | -21.00K | 0 | 0 | |||
| Shares Outstanding | 14.86M | 12.82M | 2.13M | 2.12M | 2.11M | |||
| Tangible Book Value per Share | 20.8936 | 14.5059 | 44.2453 | 67.2332 | 90.4592 | |||
| Total Shareholders' Equity | 310.38M | 186.02M | 94.33M | 142.86M | 191.22M | |||
| TOTAL LIABILITIES AND EQUITY | 335.73M | 222.57M | 115.95M | 163.26M | 210.52M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 20.84 | 8.72 | 8.96 | 16.67 | 24.66 | |||
| Return On Assets (ROA) | -22.38% | -16.32% | -49.64% | -37.17% | -15.81% | |||
| Return On Equity (ROE) | -24.21% | -19.52% | -61.02% | -42.48% | -17.40% | |||
All data in USD , ROIC based on taxRate of 0.21